These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 30569080)

  • 1. Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research.
    Hampel H; Mesulam MM; Cuello AC; Khachaturian AS; Vergallo A; Farlow MR; Snyder PJ; Giacobini E; Khachaturian ZS
    J Prev Alzheimers Dis; 2019; 6(1):2-15. PubMed ID: 30569080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
    Hampel H; Mesulam MM; Cuello AC; Farlow MR; Giacobini E; Grossberg GT; Khachaturian AS; Vergallo A; Cavedo E; Snyder PJ; Khachaturian ZS
    Brain; 2018 Jul; 141(7):1917-1933. PubMed ID: 29850777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
    Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.
    Grothe M; Heinsen H; Teipel SJ
    Biol Psychiatry; 2012 May; 71(9):805-13. PubMed ID: 21816388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene and cell therapy for the nucleus basalis of Meynert with NGF in Alzheimer's disease.
    Eriksdotter M; Mitra S
    Handb Clin Neurol; 2021; 179():219-229. PubMed ID: 34225964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
    Counts SE; Che S; Ginsberg SD; Mufson EJ
    J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB
    Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
    Teipel S; Grothe MJ;
    J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage.
    Gonzalez S; McHugh TLM; Yang T; Syriani W; Massa SM; Longo FM; Simmons DA
    Neurobiol Dis; 2022 Jan; 162():105563. PubMed ID: 34838668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease.
    Richter N; Beckers N; Onur OA; Dietlein M; Tittgemeyer M; Kracht L; Neumaier B; Fink GR; Kukolja J
    Brain; 2018 Mar; 141(3):903-915. PubMed ID: 29309600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.
    Whitehouse PJ; Price DL; Struble RG; Clark AW; Coyle JT; Delon MR
    Science; 1982 Mar; 215(4537):1237-9. PubMed ID: 7058341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer's disease - Evidence from an MRI-based meta-analysis.
    Mieling M; Meier H; Bunzeck N
    Neurosci Biobehav Rev; 2023 Nov; 154():105393. PubMed ID: 37717861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of the basal forebrain cholinergic dysfunction in Alzheimer's disease].
    Mukhin VN
    Ross Fiziol Zh Im I M Sechenova; 2013 Jul; 99(7):793-804. PubMed ID: 25470916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reimagining cholinergic therapy for Alzheimer's disease.
    Giacobini E; Cuello AC; Fisher A
    Brain; 2022 Jul; 145(7):2250-2275. PubMed ID: 35289363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer's Cholinergic Atrophy.
    Do Carmo S; Kannel B; Cuello AC
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease.
    Cavedo E; Grothe MJ; Colliot O; Lista S; Chupin M; Dormont D; Houot M; Lehéricy S; Teipel S; Dubois B; Hampel H;
    Sci Rep; 2017 Sep; 7(1):11706. PubMed ID: 28916821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia.
    Kim HJ; Moon WJ; Han SH
    J Alzheimers Dis; 2013; 35(1):129-36. PubMed ID: 23364137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: Targeting the Cholinergic System.
    Ferreira-Vieira TH; Guimaraes IM; Silva FR; Ribeiro FM
    Curr Neuropharmacol; 2016; 14(1):101-15. PubMed ID: 26813123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.